Log in

NASDAQ:MGENMiragen Therapeutics SEC Filings & 10K Form

$0.94
-0.02 (-2.09 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.92
Now: $0.94
$0.95
50-Day Range
$0.63
MA: $0.99
$1.42
52-Week Range
$0.31
Now: $0.94
$2.47
Volume649,200 shs
Average Volume3.03 million shs
Market Capitalization$49.79 million
P/E RatioN/A
Dividend YieldN/A
Beta2.32

SEC Filings

Miragen Therapeutics (NASDAQ:MGEN) SEC Filings

DateFilerForm TypeView
06/25/2020
7:42 PM
Miragen Therapeutics (Issuer)
Rauch Lee M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/23/2020
8:17 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2020
4:35 PM
Hatfield Jeffrey S. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
4:21 PM
Miragen Therapeutics (Issuer)
TURNER JOSEPH L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
4:18 PM
Miragen Therapeutics (Issuer)
Morris Arlene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
4:16 PM
KOCH KEVIN (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
4:13 PM
Hughes Thomas E. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
4:09 PM
Bowden Christopher (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
3:15 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2020
11:15 PM
Miragen Therapeutics (Filer)
Form EFFECT
04/10/2020
3:18 PM
Miragen Therapeutics (Filer)
Form DEFA14A
04/10/2020
3:17 PM
Miragen Therapeutics (Filer)
Form DEF 14A
03/27/2020
3:16 PM
Miragen Therapeutics (Filer)
Form PRE 14A
03/17/2020
3:22 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
3:25 PM
Miragen Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2020
5:24 PM
Escolar Diana (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:21 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:18 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
5:58 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/13/2020
8:44 AM
683 Capital Partners, LP (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G/A
02/07/2020
4:03 PM
Miragen Therapeutics (Filer)
Form 424B5
02/07/2020
8:18 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2020
4:29 PM
Miragen Therapeutics (Filer)
Form 424B5
01/30/2020
6:01 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2019
5:07 PM
Escolar Diana (Reporting)
Miragen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2019
3:05 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
4:12 PM
Miragen Therapeutics (Filer)
Form D/A
10/31/2019
4:00 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
7:30 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
5:16 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:00 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
7:01 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2019
4:18 PM
Miragen Therapeutics (Issuer)
TURNER JOSEPH L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:17 PM
Miragen Therapeutics (Issuer)
Morris Arlene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:16 PM
KOCH KEVIN (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:15 PM
Hughes Thomas E. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:14 PM
Hatfield Jeffrey S. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:12 PM
Bowden Christopher (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
6:15 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
3:01 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
3:46 PM
Miragen Therapeutics (Filer)
Form DEFA14A
05/03/2019
3:35 PM
Miragen Therapeutics (Filer)
Form DEF 14A
04/29/2019
6:16 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
6:15 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2019
4:24 PM
Hughes Thomas E. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:16 PM
Miragen Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/14/2019
9:45 AM
Miragen Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2019
3:02 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2019
3:34 PM
Miragen Therapeutics (Issuer)
RUBIN PAUL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:32 PM
Levy Adam Scott (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:25 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
3:08 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2019
6:21 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
3:06 PM
683 Capital Partners, LP (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G
12/20/2018
6:15 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2018
6:15 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2018
6:16 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2018
12:25 PM
Miragen Therapeutics (Filer)
Form CT ORDER
11/13/2018
9:38 AM
FMR LLC (Filed by)
Miragen Therapeutics (Subject)
Form SC 13G/A
11/07/2018
4:17 PM
Miragen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
3:02 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2018
3:38 PM
Hughes Thomas E. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2018
11:00 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2018
4:51 PM
Levy Adam Scott (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2018
4:48 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2018
4:44 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2018
9:30 AM
Miragen Therapeutics (Filer)
Form CT ORDER
08/09/2018
3:18 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2018
3:06 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
3:34 PM
Miragen Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
08/06/2018
3:16 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2018
6:15 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2018
3:49 PM
Miragen Therapeutics (Issuer)
TURNER JOSEPH L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
3:46 PM
Miragen Therapeutics (Issuer)
Morris Arlene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
3:44 PM
KOCH KEVIN (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
3:41 PM
Hughes Thomas E. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
3:38 PM
Hatfield Jeffrey S. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
3:35 PM
Bowden Christopher (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
3:31 PM
Booth Bruce (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
3:17 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2018
6:42 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2018
11:46 AM
Miragen Therapeutics (Filer)
Form CT ORDER
05/09/2018
4:20 PM
Miragen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2018
3:15 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
3:18 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2018
3:18 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2018
6:13 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2018
4:04 PM
Miragen Therapeutics (Filer)
Form 10-K/A
04/06/2018
5:30 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2018
7:31 AM
Miragen Therapeutics (Filer)
Form 8-K/A
03/27/2018
6:17 AM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2018
5:06 AM
Miragen Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2018
3:16 PM
Miragen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2018
6:11 PM
Levy Adam Scott (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2018
6:09 PM
Leverone Jason A. (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2018
6:06 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2018
3:36 PM
Marshall William Stuart (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2018
3:59 PM
Booth Bruce (Reporting)
Miragen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2018
3:06 PM
Miragen Therapeutics (Filer)
Form 424B5
02/05/2018
5:20 AM
Miragen Therapeutics (Filer)
Form 424B5
This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.